These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 22418036)

  • 21. Caco-2/TC7 cell line characterization for intestinal absorption: how reliable is this in vitro model for the prediction of the oral dose fraction absorbed in human?
    Turco L; Catone T; Caloni F; Di Consiglio E; Testai E; Stammati A
    Toxicol In Vitro; 2011 Feb; 25(1):13-20. PubMed ID: 20732406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of intestinal absorption enhancement and local mucosal toxicity of two promoters. I. Studies in isolated rat and human colonic mucosae.
    Maher S; Kennelly R; Bzik VA; Baird AW; Wang X; Winter D; Brayden DJ
    Eur J Pharm Sci; 2009 Nov; 38(4):291-300. PubMed ID: 19737613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.
    Sugano K
    Int J Pharm; 2009 May; 373(1-2):55-61. PubMed ID: 19429288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal perfusion with mesenteric blood sampling in wild-type and knockout mice: evaluation of a novel tool in biopharmaceutical drug profiling.
    Mols R; Brouwers J; Schinkel AH; Annaert P; Augustijns P
    Drug Metab Dispos; 2009 Jun; 37(6):1334-7. PubMed ID: 19273528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo permeability experiments in excised rat intestinal tissue and in vitro solubility measurements in aspirated human intestinal fluids support age-dependent oral drug absorption.
    Annaert P; Brouwers J; Bijnens A; Lammert F; Tack J; Augustijns P
    Eur J Pharm Sci; 2010 Jan; 39(1-3):15-22. PubMed ID: 19837159
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
    Panchagnula R; Bansal T; Varma MV; Kaul CL
    Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prediction of in vivo intestinal absorption enhancement on P-glycoprotein inhibition, from rat in situ permeability.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Aug; 94(8):1694-704. PubMed ID: 15986467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Site of drug absorption after oral administration: assessment of membrane permeability and luminal concentration of drugs in each segment of gastrointestinal tract.
    Masaoka Y; Tanaka Y; Kataoka M; Sakuma S; Yamashita S
    Eur J Pharm Sci; 2006 Nov; 29(3-4):240-50. PubMed ID: 16876987
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prediction of drug intestinal absorption in human using the Ussing chamber system: A comparison of intestinal tissues from animals and humans.
    Miyake M; Koga T; Kondo S; Yoda N; Emoto C; Mukai T; Toguchi H
    Eur J Pharm Sci; 2017 Jan; 96():373-380. PubMed ID: 27721045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of in vitro and in vivo models for the oral absorption of peptide drugs.
    Föger F; Kopf A; Loretz B; Albrecht K; Bernkop-Schnürch A
    Amino Acids; 2008 Jun; 35(1):233-41. PubMed ID: 17726639
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of the MechPeff model to predict passive effective intestinal permeability in the different regions of the rodent small intestine and colon.
    Pade D; Jamei M; Rostami-Hodjegan A; Turner DB
    Biopharm Drug Dispos; 2017 Mar; 38(2):94-114. PubMed ID: 28214380
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of regional mechanisms responsible for poor oral absorption in humans of a modified release preparation of the alpha-adrenoreceptor antagonist, 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4 tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline (UK-338,003): the rational use of ex vivo intestine to predict in vivo absorption.
    Collett A; Stephens RH; Harwood MD; Humphrey M; Dallman L; Bennett J; Davis J; Carlson GL; Warhurst G
    Drug Metab Dispos; 2008 Jan; 36(1):87-94. PubMed ID: 17932223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of an in vitro faecal degradation method for early assessment of the impact of colonic degradation on colonic absorption in humans.
    Tannergren C; Borde A; Boreström C; Abrahamsson B; Lindahl A
    Eur J Pharm Sci; 2014 Jun; 57():200-6. PubMed ID: 24514453
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Establishment of novel prediction system of intestinal absorption in humans using human intestinal tissues.
    Miyake M; Toguchi H; Nishibayashi T; Higaki K; Sugita A; Koganei K; Kamada N; Kitazume MT; Hisamatsu T; Sato T; Okamoto S; Kanai T; Hibi T
    J Pharm Sci; 2013 Aug; 102(8):2564-71. PubMed ID: 23686795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results.
    González-Alvarez I; Fernández-Teruel C; Casabó-Alós VG; Garrigues TM; Polli JE; Ruiz-García A; Bermejo M
    Biopharm Drug Dispos; 2007 Jul; 28(5):229-39. PubMed ID: 17410527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and in vitro evaluation of a novel polymeric P-glycoprotein (P-gp) inhibitor.
    Iqbal J; Hombach J; Matuszczak B; Bernkop-Schnürch A
    J Control Release; 2010 Oct; 147(1):62-9. PubMed ID: 20603165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interplay of metabolism and transport in determining oral drug absorption and gut wall metabolism: a simulation assessment using the "Advanced Dissolution, Absorption, Metabolism (ADAM)" model.
    Darwich AS; Neuhoff S; Jamei M; Rostami-Hodjegan A
    Curr Drug Metab; 2010 Nov; 11(9):716-29. PubMed ID: 21189140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited influence of P-glycoprotein on small-intestinal absorption of cilostazol, a high absorptive permeability drug.
    Toyobuku H; Tamai I; Ueno K; Tsuji A
    J Pharm Sci; 2003 Nov; 92(11):2249-59. PubMed ID: 14603510
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marked impact of P-glycoprotein on the absorption of TAK-427 in rats.
    Takeuchi T; Nonaka M; Yoshitomi S; Higuchi T; Ebihara T; Maeshiba Y; Kawase M; Asahi S
    Biopharm Drug Dispos; 2008 Sep; 29(6):311-23. PubMed ID: 18651556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine.
    Werle M; Hoffer M
    J Control Release; 2006 Mar; 111(1-2):41-6. PubMed ID: 16377016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.